PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medigen Vaccine Biologics Corporation, Taipei City, Taiwan.\', \'Temple University, Philadelphia, PA, 19122, USA.\', \'Department of Biotechnology and Animal Science, National Ilan University, Yilan County, Taiwan.\', \'Dynavax Technologies, Emeryville, CA, 94608, USA.\', \'Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.\', \'Genomic Research Center, Academia Sinica, Taipei, Taiwan.\', \'Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. bmtao@ibms.sinica.edu.tw.\', \'Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan. bmtao@ibms.sinica.edu.tw.\', \'Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan. yll@ibms.sinica.edu.tw.\', \'Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan. yll@ibms.sinica.edu.tw.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-88283-8
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 33888840
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all